Education
About Us
Working with TipRanks
Follow Us
Cigna Corp (CI)
NYSE:CI
CI Stock Chart & Stats
$289.82
-$1.43(-0.51%)
At close: 4:00 PM EST
$289.82
-$1.43(-0.51%)
Day’s Range― - ―
52-Week Range$239.51 - $350.00
Previous CloseN/A
Volume191.22K
Average Volume (3M)1.67M
Market Cap
$76.38B
Enterprise Value$101.23B
Total Cash (Recent Filing)$7.68B
Total Debt (Recent Filing)$31.46B
Price to Earnings (P/E)13.1
Beta0.19
Next Earnings
May 01, 2026EPS Estimate
7.57Next Dividend Ex-DateN/A
Dividend Yield2.21%
Share Statistics
EPS (TTM)8.08
Shares Outstanding267,125,820
10 Day Avg. Volume1,291,899
30 Day Avg. Volume1,669,173
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)1.75
Price to Sales (P/S)0.27
P/FCF Ratio8.73
Enterprise Value/Market Cap1.33
Enterprise Value/Revenue0.37
Enterprise Value/Gross Profit3.90
Enterprise Value/Ebitda8.45
Forecast
1Y Price Target
$336.18Price Target Upside16.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)30.3
Revenue Forecast (FY)$284.79B
Bulls Say, Bears Say
Bulls Say
PBM Business Model TransitionAdoption of a rebate-free PBM model is tracking in line with expectations and should preserve the PBM's margin profile as revenue shifts toward administrative fees and clinical program services.
Regulatory ClarityFTC settlement reduces a major regulatory overhang and clarifies requirements for the PBM transition, allowing investor focus to shift toward growth opportunities in specialty products.
Specialty And Clinical Services GrowthStrong growth in specialty and clinical services, driven by increased use of biosimilars and demand in oncology and autoimmune treatments, is expected to be the principal driver of future earnings expansion.
Bears Say
Medical Loss Ratio PressureHigher medical loss ratios and slower core specialty growth reduced reported profitability and signal ongoing margin headwinds for the core healthcare business.
Reserve Volatility And Stop-loss SeasonalityReserves decreased materially due to stop-loss seasonality and lagged claim payments, creating uncertainty about reserve adequacy and potential earnings volatility.
Reshoring And Tax ImplicationsReshoring of purchasing and GPO-related PBM activities could modestly raise the company's tax rate over time, which would weigh on net margins if not mitigated.
Cigna News
CI FAQ
What was Cigna Corp’s price range in the past 12 months?
Cigna Corp lowest stock price was $239.51 and its highest was $350.00 in the past 12 months.
What is Cigna Corp’s market cap?
Cigna Corp’s market cap is $76.38B.
When is Cigna Corp’s upcoming earnings report date?
Cigna Corp’s upcoming earnings report date is May 01, 2026 which is in 62 days.
How were Cigna Corp’s earnings last quarter?
Cigna Corp released its earnings results on Feb 05, 2026. The company reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.2.
Is Cigna Corp overvalued?
According to Wall Street analysts Cigna Corp’s price is currently Undervalued.
Does Cigna Corp pay dividends?
Cigna Corp pays a Quarterly dividend of $1.51 which represents an annual dividend yield of 2.21%. See more information on Cigna Corp dividends here
What is Cigna Corp’s EPS estimate?
Cigna Corp’s EPS estimate is 7.57.
How many shares outstanding does Cigna Corp have?
Cigna Corp has 267,125,820 shares outstanding.
What happened to Cigna Corp’s price movement after its last earnings report?
Cigna Corp reported an EPS of $8.08 in its last earnings report, beating expectations of $7.88. Following the earnings report the stock price went up 4.718%.
Which hedge fund is a major shareholder of Cigna Corp?
Currently, no hedge funds are holding shares in CI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cigna Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Cigna Corp
The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
CI Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Overall the call emphasized strong top-line and EPS growth in 2025, robust specialty and EverNorth performance, strategic clarity from the FTC settlement and PBM reform, and continued capital returns. Management acknowledged near-term charges, planned investments for the new rebate-free PBM model that will pressure cash flow and require execution, and elevated medical cost trends that influence MCR guidance. On balance, the positives (sustained revenue and earnings growth, specialty momentum, capital returns, regulatory clarity and a customer-oriented PBM model) outweigh the transitional and cost-related headwinds.View all CI earnings summariesCI Stock 12 Month Forecast
Average Price Target
$336.18
▲(16.00% Upside)
Technical Analysis
Ownership Overview
0.35% Insiders
29.78% Mutual Funds
19.56% Other Institutional Investors
26.91% Public Companies and Individual Investors